{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Active+Control+vs+Experimental+Treatment", "query": { "intervention": "Active Control vs Experimental Treatment" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 30, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Active+Control+vs+Experimental+Treatment&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-10T21:53:15.420Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00866879", "title": "Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Renal Transplant Rejection" ], "interventions": [ { "name": "Sirolimus", "type": "DRUG" }, { "name": "Demographic Data, Medical History, and Donor Data", "type": "OTHER" }, { "name": "Blood Draws for Control Group", "type": "PROCEDURE" }, { "name": "Blood Draws for Experimental Group", "type": "PROCEDURE" }, { "name": "Donor Blood Draws", "type": "PROCEDURE" }, { "name": "Donor Information", "type": "OTHER" }, { "name": "Kidney Biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 275, "start_date": "2007-06", "completion_date": "2019-03", "has_results": true, "last_update_posted_date": "2019-06-28", "last_synced_at": "2026-09-10T21:53:15.420Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00866879" }, { "nct_id": "NCT04446117", "title": "Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metastatic Prostate Cancer", "Prostate Adenocarcinoma" ], "interventions": [ { "name": "Cabozantinib", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Abiraterone Acetate", "type": "DRUG" }, { "name": "Enzalutamide", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Exelixis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 575, "start_date": "2020-10-19", "completion_date": "2026-10-16", "has_results": true, "last_update_posted_date": "2025-12-18", "last_synced_at": "2026-09-10T21:53:15.420Z", "location_count": 36, "location_summary": "Tucson, Arizona • Duarte, California • Fullerton, California + 30 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Marina del Rey", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04446117" }, { "nct_id": "NCT07285148", "title": "A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Non-Small Cell Lung Cancer", "EGFR Mutation", "Metastatic Lung Cancer", "MET Alteration" ], "interventions": [ { "name": "ANS014004 + PLB1004", "type": "DRUG" }, { "name": "ANS014004 + Osimertinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Beijing Pearl Biotechnology Limited Liability Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 253, "start_date": "2026-06", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2025-12-16", "last_synced_at": "2026-09-10T21:53:15.420Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07285148" }, { "nct_id": "NCT03926624", "title": "Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Leukemia, Myeloid, Acute" ], "interventions": [ { "name": "DFP-10917", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Azacitidine", "type": "DRUG" }, { "name": "Decitabine", "type": "DRUG" }, { "name": "Mitoxantrone", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Idarubicin", "type": "DRUG" }, { "name": "Venetoclax", "type": "DRUG" }, { "name": "Cladribine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Delta-Fly Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 167, "start_date": "2019-11-22", "completion_date": "2026-01-07", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-09-10T21:53:15.420Z", "location_count": 39, "location_summary": "Birmingham, Alabama • Gilbert, Arizona • Scottsdale, Arizona + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03926624" }, { "nct_id": "NCT04609735", "title": "Manual Therapy, Exercise and US Vs. Manual Therapy, Exercise and US for Medial Epicondylalgia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Epicondylalgia" ], "interventions": [ { "name": "Electric Dry Needling, Manual Therapy, Exercise and Ultrasound", "type": "OTHER" }, { "name": "Manual Therapy, Exercise and Ultrasound", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Alabama Physical Therapy & Acupuncture", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 110, "start_date": "2020-10-31", "completion_date": "2026-05-01", "has_results": false, "last_update_posted_date": "2025-05-18", "last_synced_at": "2026-09-10T21:53:15.420Z", "location_count": 1, "location_summary": "Fort Wayne, Indiana", "locations": [ { "city": "Fort Wayne", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04609735" }, { "nct_id": "NCT04208516", "title": "Continuous Nerve Block Block vs Combination of Single Block Plus Intravenous Lidocaine for Postoperative Pain.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "Continuous Erector Spinae Plane Nerve Block", "type": "PROCEDURE" }, { "name": "Continuous Quadratus Lumborum Nerve Block", "type": "PROCEDURE" }, { "name": "Single Erector Spinae Plane Nerve Block", "type": "PROCEDURE" }, { "name": "Single Quadratus Lumborum Nerve Block", "type": "PROCEDURE" }, { "name": "Lidocaine IV", "type": "DRUG" }, { "name": "Ropivacaine 0.5% Injectable Solution", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Dexmedetomidine", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Jeremy Kearns", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 17, "start_date": "2021-05-26", "completion_date": "2022-08-18", "has_results": true, "last_update_posted_date": "2023-09-13", "last_synced_at": "2026-09-10T21:53:15.420Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04208516" }, { "nct_id": "NCT02365064", "title": "CPAP vs ASV for Insomnia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Insomnia", "Sleep-Disordered Breathing" ], "interventions": [ { "name": "AirCurve 10 ASV", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "ResMed", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 78, "start_date": "2015-02", "completion_date": "2017-12-01", "has_results": true, "last_update_posted_date": "2021-09-09", "last_synced_at": "2026-09-10T21:53:15.420Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT02365064" }, { "nct_id": "NCT05111028", "title": "Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Reversal of Platelet Aggregation Inhibitors" ], "interventions": [ { "name": "Autologous Room Temperature stored Platelet transfusion", "type": "BIOLOGICAL" }, { "name": "Autologous Cold Stored Platelet transfusion", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Bloodworks", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "18 Years to 59 Years" }, "enrollment_count": 10, "start_date": "2020-11-20", "completion_date": "2021-11", "has_results": false, "last_update_posted_date": "2021-11-08", "last_synced_at": "2026-09-10T21:53:15.420Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05111028" }, { "nct_id": "NCT02391311", "title": "A Novel Neurorehabilitation Approach for Cognitive Aging With HIV", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV", "Aging" ], "interventions": [ { "name": "transcranial direct current stimulation (tDCS)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 42, "start_date": "2015-03", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2017-05-15", "last_synced_at": "2026-09-10T21:53:15.420Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT02391311" }, { "nct_id": "NCT03558984", "title": "D-PLEX 302: Efficacy and Safety of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Surgical Site Infection", "Sternal Infection", "Cardiac Surgery" ], "interventions": [ { "name": "D-PLEX", "type": "DRUG" }, { "name": "Standard of Care", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "PolyPid Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2019-12-17", "completion_date": "2022-10-24", "has_results": true, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-09-10T21:53:15.420Z", "location_count": 2, "location_summary": "Rochester, Minnesota • Huston, Texas", "locations": [ { "city": "Rochester", "state": "Minnesota" }, { "city": "Huston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03558984" } ] }